These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Synthesis and biological evaluation of new GABA-uptake inhibitors derived from proline and from pyrrolidine-2-acetic acid. Zhao X; Hoesl CE; Hoefner GC; Wanner KT Eur J Med Chem; 2005 Mar; 40(3):231-47. PubMed ID: 15725493 [TBL] [Abstract][Full Text] [Related]
5. Correlation between anticonvulsant activity and inhibitory action on glial gamma-aminobutyric acid uptake of the highly selective mouse gamma-aminobutyric acid transporter 1 inhibitor 3-hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole and its N-alkylated analogs. White HS; Sarup A; Bolvig T; Kristensen AS; Petersen G; Nelson N; Pickering DS; Larsson OM; Frølund B; Krogsgaard-Larsen P; Schousboe A J Pharmacol Exp Ther; 2002 Aug; 302(2):636-44. PubMed ID: 12130726 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of aminomethylphenol derivatives as inhibitors of the murine GABA transporters mGAT1-mGAT4. Kragler A; Höfner G; Wanner KT Eur J Med Chem; 2008 Nov; 43(11):2404-11. PubMed ID: 18395300 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 4-hydroxy-4-(4-methoxyphenyl)-substituted proline and pyrrolidin-2-ylacetic acid derivatives as GABA uptake inhibitors. Zhao X; Pabel J; Höfner GC; Wanner KT Bioorg Med Chem; 2013 Jan; 21(2):470-84. PubMed ID: 23245753 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of new derivatives of 2-substituted 4-hydroxybutanamides as GABA uptake inhibitors. Kulig K; Więckowski K; Więckowska A; Gajda J; Pochwat B; Höfner GC; Wanner KT; Malawska B Eur J Med Chem; 2011 Jan; 46(1):183-90. PubMed ID: 21111516 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and evaluation of proline and pyrrolidine based melanocortin receptor agonists. A conformationally restricted dipeptide mimic approach. Tian X; Field TB; Switzer AG; Mazur AW; Ebetino FH; Wos JA; Berberich SM; Jayasinghe LR; Obringer CM; Dowty ME; Pinney BB; Farmer JA; Crossdoersen D; Sheldon RJ J Med Chem; 2006 Jul; 49(15):4745-61. PubMed ID: 16854081 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and SAR studies of GABA uptake inhibitors derived from 2-substituted pyrrolidine-2-yl-acetic acids. Steffan T; Renukappa-Gutke T; Höfner G; Wanner KT Bioorg Med Chem; 2015 Mar; 23(6):1284-306. PubMed ID: 25698617 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of the N-diarylalkenyl-piperidinecarboxylic acid derivatives as GABA uptake inhibitors (I). Zheng J; Wen R; Luo X; Lin G; Zhang J; Xu L; Guo L; Jiang H Bioorg Med Chem Lett; 2006 Jan; 16(1):225-7. PubMed ID: 16246548 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation, and pharmacokinetic study of prolyl-1-piperazinylacetic acid and prolyl-4-piperidinylacetic acid derivatives as VLA-4 antagonists. Chiba J; Takayama G; Takashi T; Yokoyama M; Nakayama A; Baldwin JJ; McDonald E; Moriarty KJ; Sarko CR; Saionz KW; Swanson R; Hussain Z; Wong A; Machinaga N Bioorg Med Chem; 2006 Apr; 14(8):2725-46. PubMed ID: 16377201 [TBL] [Abstract][Full Text] [Related]
13. Role of GABA transporter 3 in GABAergic synaptic transmission at striatal output neurons. Kirmse K; Kirischuk S; Grantyn R Synapse; 2009 Oct; 63(10):921-9. PubMed ID: 19588470 [TBL] [Abstract][Full Text] [Related]
14. 2-Aryl(pyrrolidin-4-yl)acetic acids are potent agonists of sphingosine-1-phosphate (S1P) receptors. Yan L; Budhu R; Huo P; Lynch CL; Hale JJ; Mills SG; Hajdu R; Keohane CA; Rosenbach MJ; Milligan JA; Shei GJ; Chrebet G; Bergstrom J; Card D; Mandala SM Bioorg Med Chem Lett; 2006 Jul; 16(13):3564-8. PubMed ID: 16621543 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of N-substituted nipecotic acid derivatives with an unsymmetrical bis-aromatic residue attached to a vinyl ether spacer as potential GABA uptake inhibitors. Quandt G; Höfner G; Wanner KT Bioorg Med Chem; 2013 Jun; 21(11):3363-78. PubMed ID: 23598250 [TBL] [Abstract][Full Text] [Related]
16. New prolyl oligopeptidase inhibitors developed from dicarboxylic acid bis(l-prolyl-pyrrolidine) amides. Wallén EA; Christiaans JA; Jarho EM; Forsberg MM; Venäläinen JI; Männistö PT; Gynther J J Med Chem; 2003 Oct; 46(21):4543-51. PubMed ID: 14521416 [TBL] [Abstract][Full Text] [Related]
17. Transport of pharmacologically active proline derivatives by the human proton-coupled amino acid transporter hPAT1. Metzner L; Kalbitz J; Brandsch M J Pharmacol Exp Ther; 2004 Apr; 309(1):28-35. PubMed ID: 14718599 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of GABA uptake in subcellular fractions of bovine frontal cortex and brainstem. Höfner G; Wanner KT Neurosci Lett; 2004 Jun; 364(1):53-7. PubMed ID: 15193755 [TBL] [Abstract][Full Text] [Related]
19. Stereospecific synthesis and structure-activity relationships of unsymmetrical 4,4-diphenylbut-3-enyl derivatives of nipecotic acid as GAT-1 inhibitors. Pizzi DA; Leslie CP; Di Fabio R; Seri C; Bernasconi G; Squaglia M; Carnevale G; Falchi A; Greco E; Mangiarini L; Negri M Bioorg Med Chem Lett; 2011 Jan; 21(1):602-5. PubMed ID: 21134748 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and pharmacological evaluation of new 4,4-diphenylbut-3-enyl derivatives of 4-hydroxybutanamides as GABA uptake inhibitors. Kowalczyk P; Höfner G; Wanner KT; Kulig K Acta Pol Pharm; 2012; 69(1):157-60. PubMed ID: 22574521 [No Abstract] [Full Text] [Related] [Next] [New Search]